Published in J Virol on September 01, 1995
In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. J Virol (2008) 3.79
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol (2000) 3.27
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol (2003) 3.25
Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J Virol (2003) 2.93
DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids. EMBO J (2001) 2.43
Subcellular compartmentalization of adeno-associated virus type 2 assembly. J Virol (1997) 2.31
Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure. J Virol (2000) 1.98
Structurally mapping the diverse phenotype of adeno-associated virus serotype 4. J Virol (2006) 1.97
Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol (1999) 1.94
AAV hybrid serotypes: improved vectors for gene delivery. Curr Gene Ther (2005) 1.80
A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc Natl Acad Sci U S A (2010) 1.78
Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. J Virol (1995) 1.71
Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. J Virol (2004) 1.67
Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses. J Virol (2002) 1.64
Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus. J Virol (2008) 1.50
Heparin binding induces conformational changes in Adeno-associated virus serotype 2. J Struct Biol (2008) 1.44
Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment. J Virol (2002) 1.35
Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly. J Virol (2006) 1.33
Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins. J Virol (1997) 1.28
The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. J Virol (2011) 1.23
Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells. J Virol (1997) 1.23
In vitro packaging of adeno-associated virus DNA. J Virol (1998) 1.22
Adeno-associated virus type 2 protein interactions: formation of pre-encapsidation complexes. J Virol (1999) 1.20
Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates. Mol Ther (2008) 1.20
Production of human papillomavirus type 16 virus-like particles in transgenic plants. J Virol (2003) 1.15
Identification of cellular proteins that interact with the adeno-associated virus rep protein. J Virol (2008) 1.12
Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20. Virology (2012) 1.09
Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity. Front Microbiol (2011) 1.08
High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant. J Virol (1995) 1.07
Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1. J Virol (2006) 1.06
Properties of the adeno-associated virus assembly-activating protein. J Virol (2012) 1.06
Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6). Virology (2011) 1.05
OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy. Hum Gene Ther (2014) 1.03
Subcellular localization of Aleutian mink disease parvovirus proteins and DNA during permissive infection of Crandell feline kidney cells. J Virol (1996) 1.03
Characterization of adenovirus-induced inverted terminal repeat-independent amplification of integrated adeno-associated virus rep-cap sequences. J Virol (2001) 0.99
The cellular TATA binding protein is required for rep-dependent replication of a minimal adeno-associated virus type 2 p5 element. J Virol (2005) 0.98
Impact of capsid conformation and Rep-capsid interactions on adeno-associated virus type 2 genome packaging. J Virol (2006) 0.96
Expression profiles of bovine adeno-associated virus and avian adeno-associated virus display significant similarity to that of adeno-associated virus type 5. J Virol (2006) 0.94
Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry. J Virol (2012) 0.94
Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated form. J Virol (2004) 0.92
The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing. J Virol (2012) 0.90
Identification of rep-associated factors in herpes simplex virus type 1-induced adeno-associated virus type 2 replication compartments. J Virol (2010) 0.83
Avian adeno-associated virus vector efficiently transduces neurons in the embryonic and post-embryonic chicken brain. PLoS One (2012) 0.79
Chemical Modulation of Endocytic Sorting Augments Adeno-associated Viral Transduction. J Biol Chem (2015) 0.77
Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies. J Virol Methods (2016) 0.75
Relevance of assembly-activating protein for Adeno-associated virus vector production and capsid protein stability in mammalian and insect cells. J Virol (2017) 0.75
Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol (1990) 61.47
ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES. Science (1965) 9.77
Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol (1983) 7.52
An octamer of histones in chromatin and free in solution. Proc Natl Acad Sci U S A (1975) 7.35
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1990) 7.06
Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J (1991) 6.13
The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell (1990) 5.98
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J Virol (1984) 5.89
Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J Virol (1984) 4.98
Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol (1981) 3.72
Positive and negative autoregulation of the adeno-associated virus type 2 genome. J Virol (1986) 3.67
Factors that bind to adeno-associated virus terminal repeats. J Virol (1989) 3.56
Parvovirus replication. Microbiol Rev (1990) 3.37
Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product. Mol Cell Biol (1986) 3.34
Structural proteins of adenovirus-associated viruses. J Virol (1971) 3.03
Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication. Virology (1989) 2.91
Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization. J Virol (1992) 2.84
Adeno-associated viruses: an update. Adv Virus Res (1987) 2.71
Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. J Virol (1989) 2.60
Characterization of adenovirus-associated virus-induced polypeptides in KB cells. J Virol (1978) 2.40
Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins. J Virol (1993) 2.22
In vitro replication of adeno-associated virus DNA. J Virol (1994) 2.09
Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein. J Virol (1988) 2.03
Synthesis of adeno-associated virus structural proteins requires both alternative mRNA splicing and alternative initiations from a single transcript. J Virol (1988) 1.89
Characterization of adeno-associated virus rep proteins in human cells by antibodies raised against rep expressed in Escherichia coli. Virology (1987) 1.85
Adeno-associated virus rep proteins produced in insect and mammalian expression systems: wild-type and dominant-negative mutant proteins bind to the viral replication origin. Virology (1991) 1.84
Assembly of adeno-associated virus. Virology (1980) 1.71
Host range transforming gene of polyoma virus plays a role in virus assembly. Proc Natl Acad Sci U S A (1983) 1.69
Adeno-associated virus rep protein synthesis during productive infection. J Virol (1989) 1.54
Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J Virol (1992) 1.52
Virion assembly defect of polyomavirus hr-t mutants: underphosphorylation of major capsid protein VP1 before viral DNA encapsidation. J Virol (1985) 1.50
Organization of the adeno-associated virus (AAV) capsid gene: mapping of a minor spliced mRNA coding for virus capsid protein 1. Virology (1988) 1.31
Mutations in the carboxy terminus of adeno-associated virus 2 capsid proteins affect viral infectivity: lack of an RGD integrin-binding motif. J Gen Virol (1994) 1.23
Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro. J Virol (1993) 1.19
Site-directed mutagenesis of adeno-associated virus type 2 structural protein initiation codons: effects on regulation of synthesis and biological activity. J Virol (1994) 1.19
Nuclear subcompartmentalization of simian virus 40 large T antigen: evidence for in vivo regulation of biochemical activities. J Virol (1989) 1.12
Partition of E1A proteins between soluble and structural fractions of adenovirus-infected and -transformed cells. J Virol (1986) 1.09
Adeno-associated viruses having nonsense mutations in the capsid genes: growth in mammalian cells containing an inducible amber suppressor. Virology (1991) 1.08
Separation of host range from transformation functions of the hr-t gene of polyomavirus. Virology (1989) 1.04
Nuclear matrix modifications at different stages of infection by herpes simplex virus type 1. J Gen Virol (1985) 1.01
SV40 large T antigen functions at two distinct steps in virion assembly. Virology (1994) 1.01
Simian virus 40 large T antigen host range domain functions in virion assembly. J Virol (1994) 0.95
Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther (1998) 4.03
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol (2003) 3.25
DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids. EMBO J (2001) 2.43
Subcellular compartmentalization of adeno-associated virus type 2 assembly. J Virol (1997) 2.31
Molecular characterization of a karyophilic, histone-binding protein: cDNA cloning, amino acid sequence and expression of nuclear protein N1/N2 of Xenopus laevis. EMBO J (1986) 2.25
Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm. J Biol Chem (1994) 2.23
Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol (2001) 2.02
Co-existence of two different types of soluble histone complexes in nuclei of Xenopus laevis oocytes. J Biol Chem (1985) 1.76
Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. Gene Ther (1999) 1.73
Interaction of Xenopus lamins A and LII with chromatin in vitro mediated by a sequence element in the carboxyterminal domain. Exp Cell Res (1991) 1.71
Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. J Virol (1995) 1.71
Immunological localization of a major karyoskeletal protein in nucleoli of oocytes and somatic cells of Xenopus laevis. J Cell Biol (1982) 1.66
Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system. Hum Gene Ther (1999) 1.64
Soluble acidic complexes containing histones H3 and H4 in nuclei of Xenopus laevis oocytes. Cell (1982) 1.60
Structural features of the 26 S proteasome complex. J Mol Biol (1993) 1.54
Electron cryo-microscopy and image reconstruction of adeno-associated virus type 2 empty capsids. EMBO Rep (2001) 1.53
Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J Virol (1992) 1.52
Characterization of a type IV collagen major cell binding site with affinity to the alpha 1 beta 1 and the alpha 2 beta 1 integrins. J Cell Biol (1991) 1.41
[Socioeconomic incidences and prognostic factors of low back pain caused by occupational injuries among the hospital personnel of Grenoble University Hospital Center]. Rev Rhum Ed Fr (1993) 1.39
Identification of a widespread nuclear actin binding protein. Nature (1989) 1.38
Ligand-dependent and -independent integrin focal contact localization: the role of the alpha chain cytoplasmic domain. Mol Biol Cell (1993) 1.29
Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins. J Virol (1997) 1.28
Argyrophilic nuclear and nucleolar proteins of Xenopus laevis oocytes identified by gel electrophoresis. Exp Cell Res (1982) 1.24
The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. J Virol (2011) 1.23
Mutations in the carboxy terminus of adeno-associated virus 2 capsid proteins affect viral infectivity: lack of an RGD integrin-binding motif. J Gen Virol (1994) 1.23
Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther (2007) 1.23
Adeno-associated virus type 2-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) replication: involvement of p78rep/p68rep and the HIV-1 long terminal repeat. J Gen Virol (1992) 1.22
Adeno-associated virus type 2 protein interactions: formation of pre-encapsidation complexes. J Virol (1999) 1.20
Rhizocticin A, an antifungal phosphono-oligopeptide of Bacillus subtilis ATCC 6633: biological properties. Arch Microbiol (1990) 1.18
A nucleolar skeleton of protein filaments demonstrated in amplified nucleoli of Xenopus laevis. J Cell Biol (1981) 1.15
The 22 S cylinder particles of Xenopus laevis. I. Biochemical and electron microscopic characterization. Eur J Cell Biol (1983) 1.15
The adeno-associated virus type 2 regulatory proteins rep78 and rep68 interact with the transcriptional coactivator PC4. J Virol (1999) 1.14
Purification of Thermotoga maritima enzymes for the degradation of cellulosic materials. Appl Environ Microbiol (1995) 1.13
Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. Gene Ther (2003) 1.12
Assembly of adeno-associated virus type 2 capsids in vitro. J Gen Virol (1997) 1.11
Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins. J Virol (1997) 1.10
Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum Gene Ther (1999) 1.10
High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant. J Virol (1995) 1.07
High mobility group proteins of amphibian oocytes: a large storage pool of a soluble high mobility group-1-like protein and involvement in transcriptional events. J Cell Biol (1983) 1.06
Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors. Gene Ther (2011) 1.05
Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library. Gene Ther (2010) 1.05
The 22 S cylinder particles of Xenopus laevis. II. Immunological characterization and localization of their proteins in tissues and cultured cells. Eur J Cell Biol (1983) 1.03
Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33). Trop Med Parasitol (1992) 1.03
Hydro-MRI in Crohn's disease: appraisal of disease activity. Invest Radiol (2000) 1.01
Transcranial color-coded duplex sonography of intracranial veins and sinuses in adults. Reference data from 130 volunteers. Stroke (1999) 1.00
Cell lines inducibly expressing the adeno-associated virus (AAV) rep gene: requirements for productive replication of rep-negative AAV mutants. J Virol (1994) 0.99
The glutamine synthetase from Azotobacter vinelandii: purification, characterization, regulation and localization. Eur J Biochem (1978) 0.99
Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved. Drug Metab Dispos (1997) 0.98
Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction. Gene Ther (2007) 0.98
Two-tone suppression and combination tone generation as computations performed by the Hopf cochlea. Phys Rev Lett (2004) 0.95
Acanthocheilonema viteae: vaccination of jirds with irradiation-attenuated stage-3 larvae and with exported larval antigens. Exp Parasitol (1991) 0.93
Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats. Gene Ther (2008) 0.92
Fast spike pattern detection using the correlation integral. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 0.91
Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholamban. Gene Ther (2006) 0.90
Assembly and function of integrin receptors is dependent on opposing alpha and beta cytoplasmic domains. Mol Biol Cell (1995) 0.90
Selective inactivation of nitrogenase in Azotobacter vinelandii batch cultures. J Bacteriol (1976) 0.89
3-D coculture of hepatic sinusoidal cells with primary hepatocytes-design of an organotypical model. Exp Cell Res (1996) 0.89
A generalization of the van-der-Pol oscillator underlies active signal amplification in Drosophila hearing. Eur Biophys J (2006) 0.89
Proteins regulating actin assembly in oogenesis and early embryogenesis of Xenopus laevis: gelsolin is the major cytoplasmic actin-binding protein. J Cell Biol (1988) 0.88
Prevalence of antibodies to Borrelia burgdorferi and tick-borne encephalitis virus in an endemic region in southern Germany. Zentralbl Bakteriol (1997) 0.86
Molecular cloning of an immunodominant antigen of Onchocerca volvulus. J Exp Med (1988) 0.86
Essential auditory contrast-sharpening is preneuronal. Proc Natl Acad Sci U S A (2004) 0.85
mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles. Biochem Biophys Res Commun (1990) 0.85
Evaluation of pedal lymphangiography in staging non-seminomatous testicular carcinoma. J Urol (1977) 0.85
Limit cycles, noise, and chaos in hearing. Microsc Res Tech (2004) 0.84
Ultrastructure of the approximately 26S complex containing the approximately 20S cylinder particle (multicatalytic proteinase/proteasome). Eur J Cell Biol (1991) 0.84
Biotransformation of cerivastatin in mice, rats, and dogs in vivo. Drug Metab Dispos (1998) 0.83
Acanthocheilonema viteae: vaccination with irradiated L3 induces resistance in three species of rodents (Meriones unguiculatus, Mastomys coucha, Mesocricetus auratus). Trop Med Int Health (1997) 0.82
[Second reading of breast imaging at the hospital department of radiology: reasonable or waste of money?]. Rofo (2006) 0.82
Reactivation of DNA replication in erythrocyte nuclei by Xenopus egg extract involves energy-dependent chromatin decondensation and changes in histone phosphorylation. Exp Cell Res (1992) 0.82
Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocks. Eur J Cancer (1999) 0.82
Metabolic products from microorganisms. 230. Amiclenomycin-peptides, new antimetabolites of biotin. Taxonomy, fermentation and biological properties. J Antibiot (Tokyo) (1985) 0.81
Antibody responses in forest and savanna onchocerciasis in Ivory Coast. Trop Med Parasitol (1987) 0.81
[Assessment of inflammatory activity in Crohn disease with hydro-MRI]. Rofo (2000) 0.81
[Serological total diagnosis of syphilis]. Dermatol Monatsschr (1975) 0.79
The membrane-cytoplasm interface of integrin alpha subunits is critical for receptor latency. Mol Biol Cell (1996) 0.79
Differential expression of a recombinant adeno-associated virus 2 vector in human CD34+ cells and breast cancer cells. Cancer Gene Ther (2000) 0.79
Characterization of an immunodominant Onchocerca volvulus antigen with patient sera and a monoclonal antibody. J Exp Med (1988) 0.79
[Cerebral manifestations of progressive facial hemiatrophy (Romberg's disease). Nuclear spin tomographic findings and literature review]. Radiologe (1993) 0.79
Electrocardiographic changes in patients with brain tumors. Arch Neurol (1995) 0.79
Augmented transgene expression in transformed cells using a parvoviral hybrid vector. Cancer Gene Ther (2008) 0.79
Tamoxifen-regulated adenoviral E1A chimeras for the control of tumor selective oncolytic adenovirus replication in vitro and in vivo. Gene Ther (2006) 0.78
Induction of sTNF-R1 and sTNF-R2 by interferon beta-1b in correlation with clinical and MRI activity. Acta Neurol Scand (2001) 0.78
[Preparation, testing and use of a monospecific FITC-labelled antigonococcal serum]. Dermatol Monatsschr (1973) 0.78
Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosis. Acta Neurol Scand (1998) 0.78
Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity. Acta Neurol Scand (2000) 0.78
[Toxic shock syndrome in a 29-year-old patient]. MMW Munch Med Wochenschr (1981) 0.78
Computer-controlled discontinuous rotating gel electrophoresis for separation of very large DNA molecules. Anal Biochem (1989) 0.77
Tissue-specific gene expression in medullary thyroid carcinoma cells employing calcitonin regulatory elements and AAV vectors. Cancer Gene Ther (2001) 0.76
[Radiotherapy of humero-scapular periarthritis using ultra-hard photons. Evaluation by MRI findings]. Radiologe (1998) 0.76
Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors. Cancer Gene Ther (2000) 0.76